Inventor · disambiguated record
Salvatore Cuzzocrea
Also filed as: CUZZOCREA SALVATORE
9 granted patents·10 pending applications·89 citations·filing 2005–2024
80Inventor score
Files withEPITECH GROUP S P A6DISTRETTO TECNOLOGICO SICILIA MICRO E NANO SISTEMI S C A R L3EPITECH GROUP SRL2INNOVET ITALIA SRL2CSL BEHRING AG1
Top patents by PatentIndex Score
19 records- 0194US7759315B2Treatment of inflammatory conditions of the intestineCSL BEHRING AG·Filed 2005·Granted Jul 20, 2010·89 cites·16 claims
- 0278US2024315990A1Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA ReceptorEPITECH GROUP S P A·Filed 2024·Application pending·0 cites
- 0365US11744840B2N-palmitoyl-D-glucosamine in a micronized formINNOVET ITALIA SRL·Filed 2021·Granted Sep 5, 2023·0 cites·13 claims
- 0464US2021169828A1Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA ReceptorEPITECH GROUP S P A·Filed 2021·Application pending·0 cites
- 0559US11633356B2Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseasesDISTRETTO TECNOLOGICO SICILIA MICRO E NANO SISTEMI S C A R L·Filed 2020·Granted Apr 25, 2023·0 cites·6 claims
- 0658US11253526B2Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseasesDISTRETTO TECNOLOGICO SICILIA MICRO E NANO SISTEMI S C A R L·Filed 2020·Granted Feb 22, 2022·0 cites·3 claims
- 0757US2023381121A1N-palmitoylethanolamide and melatonin for use in the treatment of autism spectrum disorder and other neurobehavioral disorders similarly accompanied by restlessness, irritability, sleep disorders, and potentially stereotypiesEPITECH GROUP S P A·Filed 2023·Application pending·0 cites
- 0856US2019290669A1N-palmitoyl-d-glucosamine in a micronized formINNOVET ITALIA SRL·Filed 2019·Application pending·0 cites
- 0955US9399031B2Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseasesEPITECH GROUP SRL·Filed 2014·Granted Jul 26, 2016·0 cites·16 claims
- 1055US2022409570A1Composition of n-palmitoyl-ethanolamide and baicalein in co-micronized formEPITECH GROUP S P A·Filed 2022·Application pending·0 cites
- 1153US12370157B2Method for the treatment of COVID-19 infections with palmitoylethanolamideDELLA VALLE MARIA FEDERICA·Filed 2022·Granted Jul 29, 2025·0 cites·22 claims
- 1251US11266659B2Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseasesDISTRETTO TECNOLOGICO SICILIA MICRO E NANO SISTEMI S C A R L·Filed 2015·Granted Mar 8, 2022·0 cites·4 claims
- 1349US11819511B2Composition of N-palmitoyl-ethanolamide and Rutin in co-micronized formEPITECH GROUP S P A·Filed 2020·Granted Nov 21, 2023·0 cites·11 claims
- 1448US2017119706A1Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA ReceptorEPITECH GROUP S P A·Filed 2016·Application pending·0 cites
- 1547US9512091B2Compositions and methods for the modulation of specific amidases for N-acylethanolamines for use in the therapy of inflammatory diseasesDELLA VALLE FRANCESCO·Filed 2012·Granted Dec 6, 2016·0 cites·7 claims
- 1646US2025101491A1Phage mediated immuno-pcr for the diagnosis of alzheimer's diseaseUNIVERSITA’ DEGLI STUDI DI MESSINA·Filed 2023·Application pending·0 cites
- 1734US2016045529A1Pharmaceutical Compositions Containing Palmitoylethanolamide And Cytidine-Diphosphocholine And Methods Of Treatment TherewithEPITECH GROUP SRL·Filed 2015·Application pending·0 cites
- 1831US2020261528A1Pharmaceutical composition for the treatment of prostatic hyperplasiaPURYTRA FARM SPA·Filed 2016·Application pending·0 cites
- 1925US2016075682A1Inhibitors of nicotinamide phosphoribosyltransferase, compositions, products and uses thereofUNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →